T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy

Meredith Frank(The University of Texas MD Anderson Cancer Center), Kaylene Lu(The University of Texas MD Anderson Cancer Center), Can Erdogan(The University of Texas MD Anderson Cancer Center), Yi Han(The University of Texas Southwestern Medical Center), Jian Hu(The University of Texas MD Anderson Cancer Center), Tao Wang(Southwestern Medical Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Jianjun Zhang(The University of Texas MD Anderson Cancer Center), Alexandre Reuben(The University of Texas MD Anderson Cancer Center)
Clinical Cancer Research
November 22, 2022
Cited by 70Open Access
Full Text

Abstract

T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and of diseases like cancer. Next-generation sequencing technologies have greatly enabled the high-throughput analysis of the TCR repertoire. On the basis of our extensive experience in the field from the past decade, we provide an overview of TCR sequencing, from the initial library preparation steps to sequencing and analysis methods and finally to functional validation techniques. With regards to data analysis, we detail important TCR repertoire metrics and present several computational tools for predicting antigen specificity. Finally, we highlight important applications of TCR sequencing and repertoire analysis to understanding tumor biology and developing cancer immunotherapies.


Related Papers

No related papers found

Powered by citation graph analysis